Fairfax Financial Holdings’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-139,687
| Closed | -$472K | – | 31 |
|
|
2024
Q4 | $472K | Sell |
139,687
-31,250
| -18% | -$106K | 0.03% | 30 |
|
|
2024
Q3 | $485K | Hold |
170,937
| – | – | 0.04% | 31 |
|
|
2024
Q2 | $383K | Buy |
170,937
+19,542
| +13% | +$43.8K | 0.03% | 37 |
|
|
2024
Q1 | $333K | Hold |
151,395
| – | – | 0.03% | 42 |
|
|
2023
Q4 | $356K | Hold |
151,395
| – | – | 0.02% | 57 |
|
|
2023
Q3 | $282K | Hold |
151,395
| – | – | 0.02% | 60 |
|
|
2023
Q2 | $395K | Hold |
151,395
| – | – | 0.02% | 60 |
|
|
2023
Q1 | $245K | Hold |
151,395
| – | – | 0.01% | 64 |
|
|
2022
Q4 | $200K | Hold |
151,395
| – | – | 0.01% | 73 |
|
|
2022
Q3 | $236K | Hold |
151,395
| – | – | 0.01% | 69 |
|
|
2022
Q2 | $232K | Hold |
151,395
| – | – | 0.01% | 67 |
|
|
2022
Q1 | $388K | Hold |
151,395
| – | – | 0.01% | 65 |
|
|
2021
Q4 | $441K | Buy |
+151,395
| New | +$441K | 0.01% | 60 |
|